Friday 6 November 2026 Export ABT’s income statement to Excel — free account

Abbott Laboratories

ABT Healthcare Medical Devices

Abbott Laboratories' revenue for fiscal 2025 (year ended December 2025) was $44.3 billion, up 5.67% from fiscal 2024.

Revenue: +14.5%
EPS: −43.6%
Free cash flow: +28.9%
Total debt: +142.7%

Quarter to September 2026, against a year earlier

110.29 3.31 −2.91%

Follow ABT

Alert me

Market cap: $196.6B
P/E: 42.3×
Fwd P/E: 35.1×
Dividend yield: 2.22%
F-score: 5/9
Altman Z: 5.61
Beneish M: −2.50
Dividend safety: 62/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

	Sep '26	Jun '26	Mar '26	Dec '25	Older periods
P/E ratio Full definition →	36.88	29.37	28.76	33.68	+8 more quarters Free account
P/S ratio Full definition →	3.57	3.39	3.96	4.92
P/FCF ratio Full definition →	21.98	20.18	24.25	29.50
P/Operating CF Full definition →	69.13	63.48	136.05	65.80
P/B ratio Full definition →	3.32	3.05	3.39	4.13
Price to Tangible BV Full definition →	0.00	0.00	0.00	9.40
EV/Sales Full definition →	4.13	3.97	4.56	5.01
EV/EBITDA Full definition →	18.44	17.14	18.92	19.89
EV/Operating CF Full definition →	20.09	18.67	21.73	23.22
EV/FCF Full definition →	25.44	23.64	27.87	30.04
Quick Ratio Full definition →	—	0.80	0.84	1.02
Current Ratio Full definition →	—	1.38	1.39	1.58
Net Debt/EBITDA Full definition →	—	9.81	12.45	1.31
Debt/Assets Full definition →	—	29.86%	30.83%	14.91%
Debt/Equity Full definition →	—	0.63	0.65	0.25
Asset Turnover Full definition →	0.00	0.48	0.47	0.53
Operating CF/Net income Full definition →	0.00	2.68	1.22	1.87
Capex/Depreciation Full definition →	—	(0.47)	(0.50)	(0.87)
Interest Coverage Full definition →	4.57	4.82	7.73	18.76
Research and Development Expense of Revenue Full definition →	7.07%	7.08%	6.87%	6.41%
Selling, General and Administrative Expense of Revenue Full definition →	32.78%	31.96%	33.50%	27.31%
Intangible Assets out of Total Assets Full definition →	—	0.48	0.48	0.34
Share Based Compensation of Revenue Full definition →	0.00%	1.33%	2.84%	0.99%
Graham Net Nets Full definition →	(0.19)	(0.21)	(0.18)	(0.04)
Graham Number Full definition →	0.00	45.47	49.29	50.37
Earnings Yield Full definition →	2.71%	3.41%	3.48%	2.97%
Free Cash Flow Yield Full definition →	4.55%	4.95%	4.12%	3.39%
Revenue per Share Full definition →	0.00	7.24	6.41	6.58
Operating CF per Share Full definition →	—	1.43	0.75	1.90
Capex per Share Full definition →	—	(0.29)	(0.23)	(0.40)
Free Cash Flow per Share Full definition →	—	1.14	0.53	1.51
Cash per Share Full definition →	—	3.22	4.19	5.13
Shareholders Equity per Share Full definition →	—	29.74	30.24	30.31
Interest Debt per Share Full definition →	—	0.00	0.00	0.00
Book value per Share Full definition →	—	29.74	30.24	30.31
Free Cash Flow Full definition →	—	1,991.00	916.00	2,626.00
Working Capital Full definition →	—	6,703.00	7,131.00	9,500.00
Capital Expenditures Full definition →	—	(497.00)	(399.00)	(689.00)
Net Current Asset Value Full definition →	—	(32,936.00)	(32,220.00)	(7,946.00)
EV/EBIT Full definition →	29.94	25.17	26.69	27.58
Capex to Sales Full definition →	0.00	0.04	0.04	0.06
Price to Operating Income Full definition →	25.88	21.50	23.22	27.09
Other line items
Average Receivables Full definition →	—	8,285.50	7,768.50	7,427.00
Average Payables Full definition →	—	4,550.00	4,446.50	4,217.50
Average Inventory Full definition →	—	7,134.50	6,814.00	6,341.00
Average Assets Full definition →	—	96,607.00	95,938.50	84,063.50
Average Common Equity Full definition →	—	51,295.50	50,882.50	50,336.00

Show all line items

Columns are period end dates · fundamentals updated 2 Nov 2026

Stockrow Weekly